Literature DB >> 26629014

Assessment of liver fibrosis in the early stages with perfusion CT.

Liuhong Wang1, Jingjing Fan1, Xinfa Ding1, Jianzhong Sun1, Minming Zhang1.   

Abstract

OBJECTIVES: This work aims to assess the feasibility of perfusion CT in diagnosis of liver fibrosis in the early stage.
MATERIALS AND METHODS: Solutions of carbon tetrachloride (CCL4) were injected into the peritoneum of 45 rabbits to establish rabbit models of liver fibrosis. Perfusion CT were performed at 4-, 8-, 12- and 16- week after injection. The parametric perfusion indices of blood flow (BF), blood volume (BV), arterial liver perfusion (ALP), portal venous perfusion (PVP), and hepatic perfusion index (HPI) on perfusion maps were measured. Liver samples were scored as F0, F1, F2, F3, F4 for fibrosis.
RESULTS: In 50 rabbits, 23 rabbits survived. Of these survival rabbits, 5 rabbits were histopathologically scored as F0, 7 rabbits were F1, 8 rabbits were F2, and 3 rabbits were F3. For relatively small number of F3, multiple comparisons were made for F0 vs. F1, F1 vs. F2 and F0 vs. F2. A statistically significant difference was observed in PVP, BV, BF, ALP and HPI between F1 vs. F2 and F0 vs. F2, whereas a significant statistical difference was only achieved in PVP between F0 vs. F1. In the early stage of liver fibrosis PVP decreased with the progression of liver fibrosis, whereas HPI, ALP and BF increased with the progression of liver fibrosis. BV had no marked change.
CONCLUSIONS: Perfusion CT is feasible in diagnosis of early stage of liver fibrosis. PVP appears to be the most promising parametric perfusion index.

Entities:  

Keywords:  Liver fibrosis; animal model; perfusion CT

Year:  2015        PMID: 26629014      PMCID: PMC4658903     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  22 in total

1.  Diffusion-weighted MRI versus transient elastography in quantification of liver fibrosis in patients with chronic cholestatic liver diseases.

Authors:  Jelena Djokić Kovač; Marko Daković; Dejana Stanisavljević; Tamara Alempijević; Rada Ješić; Petar Seferović; Ružica Maksimović
Journal:  Eur J Radiol       Date:  2011-11-17       Impact factor: 3.528

Review 2.  Clinical application of hepatic CT perfusion.

Authors:  Liang Zhong; Wen-Jing Wang; Jian-Rong Xu
Journal:  World J Gastroenterol       Date:  2009-02-28       Impact factor: 5.742

3.  Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients.

Authors:  Bang-Bin Chen; Chao-Yu Hsu; Chih-Wei Yu; Shwu-Yuan Wei; Jia-Horng Kao; Hsuan-Shu Lee; Tiffany Ting-Fang Shih
Journal:  Eur Radiol       Date:  2011-08-31       Impact factor: 5.315

4.  Liver fibrosis in chronic hepatitis C virus infection: differentiating minimal from intermediate fibrosis with perfusion CT.

Authors:  Maxime Ronot; Tarik Asselah; Valérie Paradis; Nicolas Michoux; Mylène Dorvillius; Gabriel Baron; Patrick Marcellin; Bernard E Van Beers; Valérie Vilgrain
Journal:  Radiology       Date:  2010-07       Impact factor: 11.105

5.  Portal blood flow in cirrhosis of the liver.

Authors:  A H Moreno; A R Burchell; L M Rousselot; W F Panke; F Slafsky; J H Burke
Journal:  J Clin Invest       Date:  1967-03       Impact factor: 14.808

6.  Assessment of the severity of liver disease and fibrotic change: the usefulness of hepatic CT perfusion imaging.

Authors:  Kazuhiko Hashimoto; Takamichi Murakami; Keizo Dono; Masatoshi Hori; Tonsok Kim; Masayuki Kudo; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Hiroaki Nagano; Koji Umeshita; Hironobu Nakamura; Morito Monden
Journal:  Oncol Rep       Date:  2006-10       Impact factor: 3.906

Review 7.  Emerging therapies for liver fibrosis.

Authors:  Andrew J Fowell; John P Iredale
Journal:  Dig Dis       Date:  2006       Impact factor: 2.404

8.  Hepatic arterial buffer response in patients with advanced cirrhosis.

Authors:  Veit Gülberg; Klaus Haag; Martin Rössle; Alexander L Gerbes
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

9.  Total-liver-volume perfusion CT using 3-D image fusion to improve detection and characterization of liver metastases.

Authors:  Martijn R Meijerink; Jan Hein T M van Waesberghe; Lineke van der Weide; Petrousjka van den Tol; Sybren Meijer; Cornelis van Kuijk
Journal:  Eur Radiol       Date:  2008-05-20       Impact factor: 5.315

Review 10.  Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately?

Authors:  Susanne Bonekamp; Ihab Kamel; Steven Solga; Jeanne Clark
Journal:  J Hepatol       Date:  2008-11-08       Impact factor: 25.083

View more
  3 in total

1.  Correlation between acoustic radiation force impulse (ARFI)-based tissue elasticity measurements and perfusion parameters acquired by perfusion CT in cirrhotic livers: a proof of principle.

Authors:  Michael Esser; Michael Bitzer; Manuel Kolb; Jan Fritz; Mustafa Kurucay; Christer Ruff; Marius Horger
Journal:  J Med Ultrason (2001)       Date:  2018-06-13       Impact factor: 1.314

2.  Impact of Liver Fibrosis and Fatty Liver on T1rho Measurements: A Prospective Study.

Authors:  Shuangshuang Xie; Qing Li; Yue Cheng; Yu Zhang; Zhizheng Zhuo; Guiming Zhao; Wen Shen
Journal:  Korean J Radiol       Date:  2017-09-21       Impact factor: 3.500

3.  CT predicts liver fibrosis: Prospective evaluation of morphology- and attenuation-based quantitative scores in routine portal venous abdominal scans.

Authors:  Verena C Obmann; Nando Mertineit; Annalisa Berzigotti; Christina Marx; Lukas Ebner; Roland Kreis; Peter Vermathen; Johannes T Heverhagen; Andreas Christe; Adrian T Huber
Journal:  PLoS One       Date:  2018-07-10       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.